title: Malignant pericardial effusion: sclerotherapy or local chemotherapy?
authors.forename: C
authors.initials: C
authors.lastname: Lestuzzi
authors.forename: C
authors.initials: C
authors.lastname: Lafaras
authors.forename: A
authors.initials: A
authors.lastname: Bearz
authors.forename: R
authors.initials: R
authors.lastname: Gralec
authors.forename: E
authors.initials: E
authors.lastname: Viel
authors.forename: A
authors.initials: A
authors.lastname: Buonadonna
authors.forename: T
authors.initials: T
authors.lastname: Bischiniotis
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications; D010490:Pericardial Effusion / Q000188:drug therapy* / Q000209:etiology; D016032:Randomized Controlled Trials as Topic; D015911:Sclerotherapy / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents; D001761:Bleomycin